Fix the antibiotics pipeline

Matthew A. Cooper () and David Shlaes ()
Additional contact information
Matthew A. Cooper: Matthew A. Cooper is a professor at the Institute for Molecular Bioscience, University of Queensland, Brisbane St Lucia, QLD 4072, Australia.
David Shlaes: David Shlaes is a former vice-president at Wyeth Pharmaceuticals, and author of Antibiotics: The Perfect Storm (Springer).

Nature, 2011, vol. 472, issue 7341, 32-32

Abstract: As resistance mushrooms, governments must make development of new antibiotics financially viable for industry, say Matthew A. Cooper and David Shlaes.

Date: 2011
References: Add references at CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
https://www.nature.com/articles/472032a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:472:y:2011:i:7341:d:10.1038_472032a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/472032a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().